Stanley Bukofzer
2018 - DepoMed
In 2018, Stanley Bukofzer earned a total compensation of $2.2M as Senior Vice President and Chief Scientific and Technical Officer at DepoMed.
Compensation breakdown
| Non-Equity Incentive Plan | $260,873 |
|---|---|
| Salary | $375,012 |
| Stock Awards | $1,556,773 |
| Other | $6,054 |
| Total | $2,198,712 |
Bukofzer received $1.6M in stock awards, accounting for 71% of the total pay in 2018.
Bukofzer also received $260.9K in non-equity incentive plan, $375K in salary and $6.1K in other compensation.
Rankings
In 2018, Stanley Bukofzer's compensation ranked 5,240th out of 14,244 executives tracked by ExecPay. In other words, Bukofzer earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,240 out of 14,244 | 63rd |
Division Manufacturing | 1,979 out of 5,765 | 66th |
Major group Chemicals And Allied Products | 721 out of 2,128 | 66th |
Industry group Drugs | 602 out of 1,817 | 67th |
Industry Pharmaceutical Preparations | 463 out of 1,391 | 67th |
Source: SEC filing on April 8, 2019.
Bukofzer's colleagues
We found six more compensation records of executives who worked with Stanley Bukofzer at DepoMed in 2018.
2018
Arthur Higgins
DepoMed
Chief Executive Officer
2018
Phillip Donenberg
DepoMed
Chief Financial Officer
2018
August Moretti
DepoMed
Chief Financial Officer
2018
Matthew Gosling
DepoMed
General Counsel
2018
Santosh Vetticaden
DepoMed
Chief Medical Officer
2018
Daniel Peisert
DepoMed
Chief Financial Officer
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019